Latest News

Key Insights Alibaba Health Information Technology's significant public companies ownership suggests that the key...

For many investors, the main point of stock picking is to generate higher returns than the overall market. But if you...

Key Insights PICC Property and Casualty's significant public companies ownership suggests that the key decisions are...

Key Insights Significant control over SEEK by retail investors implies that the general public has more power to...

Key Insights Institutions' substantial holdings in Tongcheng Travel Holdings implies that they have significant...

Key Insights Significant control over SK Gas by public companies implies that the general public has more power to...

Key Insights Lebtech Berhad's estimated fair value is RM0.91 based on 2 Stage Free Cash Flow to Equity With RM0.91...

Isabella Bank (ISBA) turned in a strong set of earnings, with net profit margin climbing to 23.8% from last year’s 20.5%. Bottom-line growth accelerated sharply as EPS jumped 33% year-over-year, far outpacing the company’s five-year average growth of 2.4% per year. With minimal insider selling, quality earnings, an attractive dividend, and shares priced at $35.39, well below the estimated fair value of $43.18, investors are set to focus on ISBA’s value and income attributes this earnings...

Key Insights Skylark Holdings' estimated fair value is JP¥2,868 based on 2 Stage Free Cash Flow to Equity Skylark...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...

NOV (NOV) posted net profit margins of 4.4%, down from last year’s 12%. Earnings have surged by an impressive 73% per year over the past five years, and NOV has now achieved consistent profitability. While revenue is forecast to grow at a modest 1.2% annually, annual earnings are projected to increase by 9.6%. Investors are weighing the softer margins and dividend sustainability against NOV’s solid history of earnings growth and attractive valuation. See our full analysis for NOV. Next, we...

Daqo New Energy (NYSE:DQ) remains unprofitable, with losses having increased by 29.6% per year over the past five years and no meaningful improvement in profit margin. Despite these continued losses, revenue is forecast to grow at a robust 33.9% annually, far outpacing the broader US market's 10.1% yearly expectation. Earnings are expected to rise by a staggering 109.84% per year. Investors are likely to focus on these rapid growth forecasts as they weigh the company’s ongoing lack of...

Key Insights Significantly high institutional ownership implies SECOM's stock price is sensitive to their trading...

Shin-Etsu Chemical Co., Ltd. ( TSE:4063 ) just released its half-year report and things are looking bullish. Results...

Key Insights Using the 2 Stage Free Cash Flow to Equity, TIME dotCom Berhad fair value estimate is RM6.73 Current share...

Key Insights Significant control over YTL Corporation Berhad by private companies implies that the general public has...

Celestica (TSX:CLS) continued its impressive trajectory with revenue and net profit surging ahead of Canadian market averages. Over the past twelve months, earnings jumped by 97.1% while net profit margins rose to 6.3% from last year’s 3.9%, highlighting stronger profitability. With forecasted annual earnings growth of 16.78% and revenue growth of 16.6%, investors are watching closely as momentum shows no sign of slowing. See our full analysis for Celestica. Next, we will compare these...

FirstSun Capital Bancorp (FSUN) reported a net profit margin of 23.3% for the latest period, slightly down from last year’s 23.9%, alongside annual earnings growth of 7.4%. Over the past five years, FSUN has grown earnings at 17.6% per year, with forecasts pointing to ongoing annual earnings growth of 7.7% and revenue growth of 10.1%. With a Price-to-Earnings ratio of 10.4x, trading below both peer and industry averages, FSUN’s strong earnings quality and relative value stand out. Investors...

FTAI Aviation (FTAI) posted a 23.2% annual earnings growth forecast, eclipsing the US market’s 15.6% growth rate. Revenue is expected to expand at 13.3% per year, ahead of the market’s 10.1%. The company recently tipped into profitability and has managed to expand its net profit margin, but its latest financials were weighed down by a one-off $262 million loss. Over the past five years, annual earnings growth averaged a robust 53.7%, setting a strong backdrop for the future outlook. See our...

Universal Health Services (NYSE:UHS) delivered a standout year, with earnings climbing 34% over the past twelve months, well above its five-year average growth rate of 4.8% per year. Net profit margin improved to 8.1% from last year’s 6.7%, underscoring increasing profitability. While forecasts point to continued earnings and revenue growth ahead, both are expected to trail the broader US market. This keeps the stock’s position as a value play in the sector front of mind for investors. See...

If you’re standing at the crossroads of whether to jump into Ionis Pharmaceuticals stock, you’re not alone. Investors are weighing their options after a period of impressive gains, with Ionis closing at $73.57 and returning 14.8% over the past 30 days alone. Even more eye-catching is that the stock is up a remarkable 112.1% year to date and 85.3% over the last 12 months. Clearly, something has changed in how the market values Ionis. This could be due to a shift in sentiment, a new risk...

Everest Group (EG) saw its net profit margin fall to 3.1%, a steep drop from last year’s 16.7%. Shares now trade at $304.91, well below the estimated fair value of $1,405.68. Looking ahead, revenue is forecast to decline slightly at a -0.1% annual rate over the next three years. However, analysts expect a sharp recovery in earnings, projecting annual EPS growth of 52% and robust profit increases through to 2027. Investors face the challenge of weighing short-term margin pressures against...

We think all investors should try to buy and hold high quality multi-year winners. And we've seen some truly amazing...

Welltower (WELL) posted earnings growth of 4.9% this year, which falls below its solid 9.4% annualized pace over the past five years. Net profit margins slipped to 9.7% from 12.1% a year ago, and shares are currently trading at $179.7, notably above the estimated fair value of $170.23. Despite this, forecasts call for annual earnings growth of 24.4% and revenue to climb 14.5% per year, both comfortably ahead of the broader US market. However, questions remain about elevated valuation...